Mithilesh Jha

Title: The Innovative Contributions of Mithilesh Jha

Introduction

Mithilesh Jha is a notable inventor based in Sharon, MA (US). He has made significant contributions to the field of cancer immunotherapy, particularly through his work on anti-PD-L1 antibodies. His innovative approach aims to enhance the effectiveness of cancer treatments.

Latest Patents

Mithilesh Jha holds a patent for "Anti-PD-L1 cancer immunotherapy antibodies." This patent includes compositions and methods related to or derived from anti-PD-L1 antibodies with antibody-dependent cellular cytotoxicity (ADCC) and/or complement-dependent cytotoxicity (CDC) activities. Specifically, it features fully human antibodies that bind to PD-L1, along with PD-L1-binding antibody fragments, derivatives of such antibodies, and PD-L1-binding polypeptides comprising these fragments. This work represents a significant advancement in cancer treatment methodologies.

Career Highlights

Throughout his career, Mithilesh Jha has worked with various organizations, including 1Globe Biomedical Co., Ltd. and 1Globe Health Institute LLC. His experience in these companies has allowed him to develop and refine his innovative ideas in the biomedical field.

Collaborations

Mithilesh has collaborated with notable professionals in his field, including Chiang Jia Li and Shyam Unniraman. These collaborations have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

Mithilesh Jha's work in cancer immunotherapy exemplifies the impact of innovative thinking in the medical field. His contributions through patents and collaborations highlight the importance of research and development in combating cancer.